Repository logo
 

Expansion of outer cortical Cux2 neurons requires selective adaptations for DNA repair

Published version
Peer-reviewed

Repository DOI


Loading...
Thumbnail Image

Change log

Abstract

During mammalian evolution, upper cortical layer 2/3 excitatory neurons have shown a disproportionate expansion compared to other layers (1-4). Replicative expansion of cortical neural progenitors is associated with significant oxidative DNA damage. Here we show that Activating Transcription Factor 4 (Atf4) has new roles as a critical regulator of the DNA Damage Response, directly activating components of double stranded DNA repair, including CIRBP, Uba52 and Ebf1. Strikingly, pan-cortical knockout (Emx1cre, Atf4fl/fl) demonstrates that Atf4 is specifically required for development of upper layer 2/3 neurons, marked by expression of CUT-homeodomain protein, Cux2. Atf4 functions to repair DNA damage and attenuate cell death of embryonic radial glial progenitors in a p53-dependent manner. In particular, we show that Cold-Inducible RNA-Binding Protein (Cirbp) is a transcriptional target of Atf4 that is required for the normal phosphorylation of the key double strand DNA repair factor Ataxia-Telangiectasia Mutated (ATM). These findings establish that Atf4 is an essential regulator of the DNA Damage Response. They further indicate extraordinary requirements for DNA repair post-replicative stress in Cux2+ neurons during mammalian brain development. Intro:

Description

Keywords

Journal Title

Nature

Conference Name

Journal ISSN

0028-0836
1476-4687

Volume Title

Publisher

Nature Research

Rights and licensing

Except where otherwised noted, this item's license is described as Attribution 4.0 International
Sponsorship
Cambridge University Hospitals NHS Foundation Trust (CUH) (Unknown)
MULTIPLE SCLEROSIS SOCIETY (50)
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF) (Unknown)
European Research Council (789054)
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF) (R-202206-00503)
Wellcome Trust (108139/B/15/Z)
ERC